Phase I/II Double-blind, Randomized, Placebo-controlled, Descending Age, Dose-escalation Study of the Safety, and Immunogenicity of the Trivalent P2-VP8 Subunit Rotavirus Vaccine in Healthy South African Adults, Toddlers and Infants
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 18 Dec 2017
At a glance
- Drugs Rotavirus subunit vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions; Pharmacodynamics
- 11 Dec 2017 Planned End Date changed from 1 Oct 2017 to 1 Jan 2018.
- 11 Dec 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Jan 2018.
- 09 Jun 2017 Status changed from recruiting to active, no longer recruiting.